Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P de Cremoux

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
American Journal of Clinical Oncology|August 8, 2006
Estrogen receptors evolution in neoadjuvant aromatase inhibitor (AI) therapy for breast cancer in elderly women: stability of hormonal receptor expression during treatmentR J Salmon, S Alran, I Malka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2009
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancerF-C Bidard, C Mathiot, S Delaloge, et al.
Journal of Microscopy|January 1, 1994
Reflectance in situ hybridization (RISH): detection, by confocal reflectance laser microscopy, of gold-labelled riboprobes in breast cancer cell lines and histological specimensG Linares-Cruz, J P Rigaut, J Vassy, et al.
Medical Oncology (Northwood, London, England)|April 3, 2012
Three different KRAS statuses in three synchronous colorectal cancersL Jolissaint, W Cacheux, P Mariani, et al.
Breast Cancer Research and Treatment|January 1, 1994
Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinantE Osinaga, G Pancino, N Porchet, et al.
Hybridoma|April 1, 1991
Two monoclonal antibodies identify antigens preferentially expressed on normal human breast cells versus breast cancer cellsG Pancino, M H Mortada, C Charpin, et al.
Diagnostic Cytopathology|June 8, 2001
Cost-effectiveness of monolayers and human papillomavirus testing compared to that of conventional Papanicolaou smears for cervical cancer screening: protocol of the study of the French Society of Clinical CytologyB Cochand-Priollet, C Le Galès, P de Cremoux, et al.
British Journal of Cancer|June 1, 1994
p53 mutations and overexpression in locally advanced breast cancersA Faille, P De Cremoux, J M Extra, et al.
International Journal of Cancer|September 2, 1999
Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185(HER2/neu) protein expression in breast cancer drill biopsiesP de Cremoux, E C Martin, A Vincent-Salomon, et al.
Journal of the National Cancer Institute|April 15, 1999
p53 mutation as a genetic trait of typical medullary breast carcinomaP de Cremoux, A V Salomon, S Liva, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
American Journal of Clinical Oncology|August 8, 2006
Estrogen receptors evolution in neoadjuvant aromatase inhibitor (AI) therapy for breast cancer in elderly women: stability of hormonal receptor expression during treatmentR J Salmon, S Alran, I Malka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2009
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancerF-C Bidard, C Mathiot, S Delaloge, et al.
Journal of Microscopy|January 1, 1994
Reflectance in situ hybridization (RISH): detection, by confocal reflectance laser microscopy, of gold-labelled riboprobes in breast cancer cell lines and histological specimensG Linares-Cruz, J P Rigaut, J Vassy, et al.
Medical Oncology (Northwood, London, England)|April 3, 2012
Three different KRAS statuses in three synchronous colorectal cancersL Jolissaint, W Cacheux, P Mariani, et al.
Breast Cancer Research and Treatment|January 1, 1994
Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinantE Osinaga, G Pancino, N Porchet, et al.
Hybridoma|April 1, 1991
Two monoclonal antibodies identify antigens preferentially expressed on normal human breast cells versus breast cancer cellsG Pancino, M H Mortada, C Charpin, et al.
Diagnostic Cytopathology|June 8, 2001
Cost-effectiveness of monolayers and human papillomavirus testing compared to that of conventional Papanicolaou smears for cervical cancer screening: protocol of the study of the French Society of Clinical CytologyB Cochand-Priollet, C Le Galès, P de Cremoux, et al.
British Journal of Cancer|June 1, 1994
p53 mutations and overexpression in locally advanced breast cancersA Faille, P De Cremoux, J M Extra, et al.
International Journal of Cancer|September 2, 1999
Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185(HER2/neu) protein expression in breast cancer drill biopsiesP de Cremoux, E C Martin, A Vincent-Salomon, et al.
Journal of the National Cancer Institute|April 15, 1999
p53 mutation as a genetic trait of typical medullary breast carcinomaP de Cremoux, A V Salomon, S Liva, et al.
Pageof 6